Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

Merger between Aster DM and Quality Care India will transcend Metros with 39 Hospitals across 28 cities

Bangaluru: The mission is to expand Aster DM’s core brand promise ‘We’ll treat you well’ beyond metros and make quality care ubiquitous in India. Successful merger of two most credible healthcare majors, Aster DM Healthcare and Quality Care India Limited (QCIL) is all set to make quality care everywhere a fait accompli with 39 hospitals across 28 cities. The merger entails coming together of 4 trusted entities Aster DM, CARE Hospitals, Evercare and KIMSHEALTH.  Fusion four, the healthcare watchers say, will bring about a paradigm shift in the way the treatments are delivered in India. Compassion and quality care being guiding ethos of both the organizations, Aster DM Quality Care Limited is now a cut above the rest in healthcare domain of India.

The die was cast today (July 3) to begin a whole new chapter of quality care of patients in India.  Following successful completion of merger operations began. More than the coming together of two leading healthcare organizations, the merger creates a stronger platform with a shared purpose: expanding access to world-class healthcare by bringing specialist expertise, advanced treatment and cutting-edge medical technology closer to patients across India. In the new combined entity Dr. Azad Moopen will continue as Executive Chairman and Mr. Varun Khanna will lead the business as Managing Director and Group CEO.

With a strong footprint across South and Central India, Aster Quality Care will have a significant presence in several underpenetrated fast-growing healthcare centres beyond the metros.. These centres will play an increasingly important role in the group’s long-term strategy to decentralise affordable and advanced healthcare by expanding specialist services, investing in cutting-edge technologies and strengthening centres of excellence closer to where patients live.

Upon the combined entity becoming operational as a unified enterprise, Dr. Azad Moopen, Executive Chairman, Aster DM Quality Care, said, “The coming together of Aster and Quality Care as a single enterprise marks a defining milestone in our journey to build one of India’s most trusted and future-ready healthcare institutions. More than the combination of two healthcare networks; it is the convergence of shared values, clinical excellence, deep medical expertise and an unwavering commitment to patient care. Together, we are creating an institution that is stronger, more resilient and better positioned to address the evolving healthcare needs of India.” 

On the strategic priorities for the combined organization, Mr. Varun Khanna, Managing Director and Group CEO, Aster DM Quality Care said, “Aster DM Quality Care brings together highly complementary institutions, strong clinical ecosystems and teams united by a shared ambition to strengthen healthcare delivery in India. At Aster Quality Care patients and their families will be at the centre of every decision, with digitally enabled solutions and a strong bias for high-quality clinical outcomes. Our immediate focus is disciplined and seamless integration with continuity of patient care. We are committed to ensuring that patients, clinicians, employees and partners experience stability and consistency as we bring together systems, capabilities and best practices across the combined network.”

With 39 hospitals across 28 cities and over 10,500 beds, Aster DM Quality Care is uniquely positioned to expand access to specialist care, advanced treatment and cutting-edge medical technology across India’s tier 2 and tier 3 cities, reducing the need for patients to travel to metropolitan centres for complex healthcare.

From introducing the first LINAC-based radiation therapy system in Nagercoil and establishing India’s first 3D biplanar catheterization laboratories and cranial and spinal independent neuro robotic surgery programs along with expanding robotic-assisted surgery programmes in cities such as Kolhapur and Kannur with Guntur and Vijaywada in pipeline, Aster and Quality Care have demonstrated that world-class healthcare need not be confined to India’s largest metros. Building on this foundation, the combined entity will accelerate investments by adding 6 high end IGRT LINAC-based radiation therapy systems in cities like Kannur, Vijaywada, Kottakkal; 6-8 robotic surgical platforms, 2 digital minimally invasive intervention suites, advanced MRI infrastructure and other next-generation clinical capabilities like digital pet scan, digital mammography units, and 4 fluorescence image guided surgical equipment in tier 2 cities.

The group’s combined bed strength is expected to grow to over 15,000 beds over the coming years, helping expand access to affordable care across the country. With more than 45,000 healthcare professionals, the combined entity brings together one of India’s most extensive clinical ecosystems, enabling greater collaboration among doctors, nurses and caregivers while strengthening access to high-quality care across the network.

Related Posts

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

In a Trailblazing approach, Aakash Healthcare Surgeons rebuilt Children’s Lower Limbs using Mothers’ Bone New Delhi: A 16-year-old girl whose thigh bone was destroyed by chronic infection in 2021 is…

Safdarjung Hospital performs its first dual kidney transplant using organs from marginal donor

The Indian Air Force airlifted the retrieved organs to Delhi from Command Hospital, Chandimandir, where the 62-year-old donor was declared brain dead. New Delhi: Vardhman Mahavir Medical College (VMMC) and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

Cancer patient dies before ‘using’ Ayurvedic treatment, hospital to pay parents Rs 63,000

Cancer patient dies before ‘using’ Ayurvedic treatment, hospital to pay parents Rs 63,000

Fake beauty products with ₹6.9L face value seized from two shops; owners arrested

Fake beauty products with ₹6.9L face value seized from two shops; owners arrested